A SerucellBio Platform Science Resource
Biology is a conversation between cells.
Not a metaphor. A literal biochemical fact. Every tissue function — repair, regeneration, structural maintenance, inflammation resolution — is downstream of what cells signal to each other. When that conversation is intact, tissue maintains itself. When it degrades, tissue fails. At every scale. In every organ.
Scroll to explore the platform ↓
01 — The Operating System
Cell-to-cell communication is not a feature of biology. It is the operating system.
Every cell in every tissue exists within a signaling environment. Keratinocytes receive instructions from fibroblasts below them. Alveolar epithelium coordinates with lung fibroblasts. Dermal papilla cells govern follicle stem cell activation through paracrine dialogue. No cell operates in isolation. No cell was designed to.
When the conversation between cell populations degrades — through senescence, fibrosis, cycling arrest, or environmental damage — the tissue it governs begins to fail. Not because a component broke. Because the instructions stopped arriving. This distinction determines what kind of intervention can actually restore tissue behavior — and what kind cannot.
- Keratinocyte ↔ Fibroblast: Epidermal–Dermal Axis · Skin.
- Alveolar Epithelium ↔ Lung Fibroblast: Alveolar–Interstitial Axis · Lung.
The signals that govern tissue behavior do not come from individual cells. They emerge from the conversation between them.
02 — The Gap
Single-target intervention operates below the layer where tissue behavior is actually governed.
The dominant model of biological medicine identifies a molecular target — a gene, a receptor, a transcript — and modulates it. This is powerful when disease is a single-component failure. But tissue failure at the systemic level is not a broken component. It is a communication breakdown. And no single-target intervention can restore a conversation.
| Single-Target Biology | Cell Communication Biology | |
|---|---|---|
| Unit of analysis | Individual cell | Cell population in dialogue |
| Mechanism | Block, degrade, or activate one target | Restore the signaling environment |
| Assumption | Disease = broken component | Disease = communication breakdown |
| Intervention | Precision molecule | Engineered multi-cell secretome |
| Output | Changed protein activity | Changed tissue behavior |
| Platform | Monoculture-derived | Co-culture emergent |
Monoculture science studies a conversation by listening to one speaker in a soundproof room. The message is partial. The biology is not.
03 — The Platform
Multi-cellular co-culture engineered for emergent signaling.
[NAMING — IBI: the static site uses “IBI / Integrative Bio Intelligence.” Your public sites retired IBI. Kept here for the gated audience; confirm whether to keep or rename.] The IBI Platform co-cultures multiple human cell lines simultaneously under controlled conditions. The secretome it produces is not the sum of what individual cell types generate in isolation. It is what emerges when those populations are in active biochemical dialogue — signals, growth factors, cytokines, and vesicle cargo that no monoculture can produce. This is not an optimization of existing secretome technology. It is access to a different biological layer entirely.
- 385 Proteins detected exclusively in co-culture — absent from all single-cell conditions.
- 40% Of the co-culture proteome appeared only when keratinocyte and fibroblast populations were in active communication.
- 60%+ Proteins show positive variance in co-culture vs. single-cell sum — a coordinated, regulated signal state, not blunt activation.
This is not addition. It is emergence.
04 — Two Axes of Proof
The same platform logic. Two independent tissue systems. Documented results.
The platform has been applied to two independent tissue communication axes — skin and lung. Each represents a distinct cell population, disease context, and therapeutic goal. The underlying operating principle is identical.
- Skin Axis — Restoration · Keratinocyte × Fibroblast: Dermal fibroblast senescence disrupts the epidermal-dermal paracrine axis; SASP output (IL-6, IL-8, MMP enzymes) degrades the matrix and corrupts the signal keratinocytes depend on. Platform output: KFS® — INCI-registered, deployed commercially via Serucell Skincare Inc. Clinical: randomized pilot, radiation-dermatitis indication. IRB approved — Marshall University IRBNet 1977269-1; PI Sanjeev Sharma, MD, Marshall Health Network.
- Lung Axis — Normalization · Pulmonary Fibroblast × MSC × Alveolar: In IPF, healthy signaling is replaced by pro-fibrotic communication; TGF-β-driven myofibroblast conversion accelerates and the tissue scars. Platform output: LEO — nebulized co-culture secretome. Preclinical: IACUC bleomycin mouse model (Aragen, PC-3768-020; 75 animals, 8 groups, 5 compounds vs. pirfenidone). Ashcroft: LEO 2.26 vs. pirfenidone 2.44 vs. vehicle 3.10. 282 de novo proteins; periostin decreased; Collagen I 358→1,422 PSMs (organized ECM restoration). Independent CRO; histopathology HistoTox Labs (J. Durrant, DACVP).
Two organs. Two disease contexts. Two independent cell populations. One platform logic. The tissue changes. The principle does not.
05 — Research Library
The published science underlying this field.
Peer-reviewed publications on intercellular signaling, cellular senescence, secretome biology, and pulmonary fibrosis. Sources from the scientific literature — not product claims or clinical assertions.
- Recent advances in dermal fibroblast senescence and skin aging. Zhang et al., Zhejiang University. Frontiers in Pharmacology, 2025. PMC12213903.
- Lifespan, Healthspan, and the Expanding Role of Cosmetic Dermatology in Longevity Science. Haykal D, et al. J Cosmetic Dermatology, 2025. PMC12703656.
- Translating Geroscience Into Clinical Longevity Dermatology. Haykal D, et al. J Cosmetic Dermatology, 2026.
- Cellular Senescence in Human Skin Aging: Leveraging Senotherapeutics. PMC, 2024. PMC10873061.
- Dermal Fibroblast Senescence: The Central Hub of Skin Aging. Int. J. Molecular Sciences, 2026. MDPI.
- Fibroblast-to-Myofibroblast Transition in IPF: Paracrine Signaling and the ECM. Current literature.
- SASP in Pulmonary Fibrosis: Mechanisms and Therapeutic Targets. Current literature.
A SerucellBio Inc. Platform Science Resource. The platform is a multi-cellular co-culture secretome technology developed by SerucellBio Inc. for research, clinical, and commercial applications across tissue systems. intelligentcellsignaling.com is a confidential scientific resource operated by SerucellBio Inc., 803 10th Street, Huntington, WV 25701. Content is informational only. No clinical efficacy claims are made or implied. Access is restricted to authorized recipients. © 2026 SerucellBio Inc. All rights reserved.